Broad Institute

AUGUST 11, 2023

When the Broad Institute became independent in 2009, she established the Broad’s animal research program and human subjects compliance office, and helped establish the Broad’s CLIA lab, where she serves as a key staff member. Donnelly received her B.A. July 2023 Previous Soumya Raychaudhuri Next Stacey Gabriel

Bioethics 52

Bioethics Compliance Science Research 52

Broad Institute

MAY 14, 2024

“Today, virtually every protein you want to produce in bacteria is made with a T7 system,” said Venki Ramakrishnan of the MRC Laboratory of Molecular Biology in Cambridge, England, and a winner of the 2009 Nobel Prize in Chemistry. There’s not a single molecular biology or biochemistry lab I know that doesn’t use T7.”

RNA 84

RNA Production Molecular Biology Laboratories 84

The Pharma Data

MARCH 13, 2021

Dr. Fei-Fei Li (44), a leading expert in artificial intelligence and Professor in the Computer Science Department at Stanford University in California, and Alberto Weisser (65), a renowned agricultural expert with decades of capital market experience in the United States. The independent candidates proposed for election are Prof.

International 52

International Engineering Science Marketing 52

thought leadership

JULY 2, 2024

In this respect, a clinical trial with a GMO must also comply with either the contained use Directive (2009/41/EC) or the deliberate release Directive (2001/18/EC). The Directive that actually applies to a clinical trial with GMOs is dependent upon the individual Member States (MS) (see Figure 1).

Trials 52

Trials Therapies Clinical Trials Regulations 52

The Pharma Data

NOVEMBER 11, 2020

Inspired by a lifelong passion for nature and a fascination with the potential to address disease using naturally derived compounds, he earned a Bachelor of Science in chemical technology at Iowa State University of Science and Technology in 1961. In 2009, he established Ironstone Separations Inc.,

Organic Chemistry 52

Organic Chemistry Science Pharmaceuticals Pharmacy 52

Drug Target Review

JUNE 29, 2023

Can you tell us about your journey in the field of science, technology, engineering and maths (STEM) and the challenges you encountered along the way? At school I was encouraged to follow science because I was good at it. Prior to joining Adaptimmune in 2009, Jo held positions at Avidex, Medigene and Immunocore.

Therapies 115

Therapies Science Production Cell Biology 115

Drug Target Review

FEBRUARY 28, 2024

Previously, Mr Ho served as a Senior Equity Research Analyst at Bank of America from 2006 to 2009 and an Equity Research Analyst at Piper Jaffray & Co. from 2003 to 2006, covering the biotechnology and life-science tools sectors. Science 294(5542):605-609 (2001). in Biochemistry from McMaster University.

Therapies 105

Therapies Engineering Molecular Biology Science 105

Drug Target Review

OCTOBER 17, 2024

While its involvement in the do-not-eat-me signal from cancer has inspired therapeutic development of this pathway for oncology, the function of the innate immune checkpoint we identified in 2009 1 extends to both innate and adaptive immune responses. 2009 Mar 5;323(5922):1722–5. References Chen GY., Tang J, Zheng P, Liu Y.

Immune Response 52

Immune Response Clinical Trials Trials Therapies 52

The Pharma Data

NOVEMBER 11, 2020

11, 2020 /PRNewswire/ — Kodiak Sciences Inc. Chief Medical & Development Officer of Kodiak Sciences. Kodiak Sciences Inc. About Kodiak Sciences Inc. Kodiak®, Kodiak Sciences®, ABC , ABC Platform and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. PALO ALTO, Calif. ,

Science 40

Science Treatment Disease Engineering 40

Drug Target Review

JUNE 21, 2023

Doi: 10.1126/science.1091317. 2009 Nov 27;326(5957):1231-5. doi: 10.1126/science.1178955. Global mapping of the yeast genetic interaction network. 2004 Feb 6;303(5659):808-13. PMID: 14764870. PMID: 14764870. Exploring genetic suppression interactions on a global scale. 2016 Nov 4;354(6312):aag0839. doi: 10.1126/science.aag0839.

Disease 111

Disease Clinical Trials Therapies Science 111

The Pharma Data

DECEMBER 7, 2020

based clinical trials investigating interventions for high blood pressure between 2009-2018, just 52 were exclusively in Black people. While the numbers grew over that decade – from 3.9% (3 of 77 trials) in 2009 to 6.2% (9 of 146) in 2018 – the increase was not enough to be statistically significant.

Treatment 52

Treatment Clinical Trials Trials Doctors 52

The Pharma Data

FEBRUARY 22, 2022

From 2009 to 2016, he led global oncology development at AstraZeneca, delivering TAGRISSO and LYNPARZA, including Senior Vice President, GMD Head of Oncology and Lead, China GMD (2013-2016). About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

Clinical Trials 52

Clinical Trials DNA Science Clinical Development 52

FDA Law Blog: Drug Discovery

FEBRUARY 2, 2023

While this hype may be warranted in some respects—a 60-year old legal provision has now been amended to acknowledge that the science of drug development is advancing—the change is mostly symbolic and is likely to take many years before we see it have a measurable impact.

Animal Testing 64

Animal Testing Biosimilars Cell Based Assays Clinical Trials 64

Codon

JULY 21, 2024

In fact, the science of animal welfare is exploding. “If we knew what we were doing, it wouldn't be science. For the millions of rodents killed annually in the name of science, their deaths ought to be as painless as possible. ” Jeff Mogil , professor of pain studies at McGill University, sees the figure differently.

Research 124

Research Engineering Disease Science 124

The Pharma Data

OCTOBER 9, 2021

We’re the Janssen Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.

Treatment 52

Treatment FDA Approval FDA Pharmaceutical Companies 52

The Pharma Data

DECEMBER 11, 2020

Studies of the technique at Oregon Health & Science University in Portland show no adverse health effects in rhesus macaque monkeys and their offspring. The researchers said the first five monkeys born in 2009 at OHSU’s Oregon National Primate Research Center with the aid of the technique all developed normally to adulthood.

Therapies 52

Therapies Clinical Trials Disease Trials 52

The Pharma Data

JANUARY 20, 2021

The CytomX clinical-stage pipeline includes potentially first-in-class product candidates against previously undruggable targets, including a CD166-targeting Probody drug conjugate wholly owned by CytomX (CX-2009) and a CD71-targeting Probody drug conjugate partnered with AbbVie (CX-2029).

Clinical Development 40

Clinical Development Therapies Drugs Science 40

LifeSciVC

APRIL 14, 2023

With data from Cooley only through 4Q22, life science venture down-rounds have spiked nearly five-fold. And huge mega-rounds for early science projects are also probably a thing of the past, which is a good thing as disciplined equity capital efficiency returns.

Marketing 52

Marketing Science Therapies Drugs 52

Agency IQ

JUNE 16, 2023

0910-AI26 September 2023 March 2023 Final Rule Stage Biologics License Applications and Master Files The Biologics Price Competition and Innovation Act of 2009 (BPCI Act) deemed any biological product approved in a new drug application (NDA) to be a biologics license application (BLA) on March 23, 2020.

Regulations 40

Regulations FDA Science Production 40

Broad Institute

AUGUST 2, 2023

in Physics from Massachusetts Institute of Technology in 2009. Unemployment reached almost 25% and then declined to under 10% over the next 15 years until the less severe recession in 2009/2010. from the University of Bristol, where she worked between the School of Psychological Science and the MRC Integrative Epidemiology Unit.

Medical Schools 52

Medical Schools Disease Science International 52

Broad Institute

OCTOBER 16, 2024

It is so important to recognize groundbreaking science and the remarkable individuals who have made a difference so more people are aware of these achievements," said Edythe Broad. "If He has a humble, self-effacing demeanor, and yet he is great at pushing people to make bold bets and to try to make the impossible possible."

Vaccine 64

Vaccine RNA Laboratories Molecular Biology 64

The Pharma Data

MAY 27, 2022

ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. a number of countries ?including including in sub-Saharan Africa.

Licensing 52

Licensing Licensing Treatment Production 52

Codon

MARCH 28, 2023

In 2009, the USC professor received millions from the Defense Advanced Research Projects Agency, or DARPA, to build a device that plugs into the brain and enhances memory recall. “I believe it would be dangerous to predict what science is going to do in the next twenty years.” The first project, REMIND, began in 2009.

Engineering 52

Engineering Research Science FDA Approval 52

PLOS: DNA Science

SEPTEMBER 21, 2023

Like the mythical Phoenix bird arising from the ashes, live get-togethers are finally replacing zoom life, bringing back the sharing of ideas and spontaneity that catalyzes insights and inspiration – especially in science and technology. The post The Festival of Genomics and Biodata 2023 Comes to Boston appeared first on DNA Science.

DNA 52

DNA Science Medical Schools Government 52

The Pharma Data

OCTOBER 21, 2020

The complete regimen combines the integrase strand transfer inhibitor (INSTI) cabotegravir, developed by ViiV Healthcare, with rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) developed by Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. About ViiV Healthcare.

Clinical Development 52

Clinical Development Therapies Clinical Trials Treatment 52

Agency IQ

JULY 26, 2024

BY LAURA DIANGELO, MPH , RACHEL COE, MSC | JUL 23, 2024 9:54 PM CDT Biosimilarity and interchangeability: A quick recap The Biologics Price Competition and Innovation (BPCI) Act of 2009 intended to increase the number of biologic products on the market by creating two types of approvals for biosimilar products.

Biosimilars 40

Biosimilars Science FDA Production 40

Agency IQ

AUGUST 4, 2023

Article 18 of Regulation (EC) No 1223/2009 prohibits the marketing of cosmetic products that involved animal testing to meet the regulation’s requirements. Action points to accelerate the reduction of animal testing in research, education and training” will address the request to modernize science.

Animal Testing 40

Animal Testing Regulations Production Research 40

Drug Target Review

SEPTEMBER 26, 2023

Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting. 2009 Sep;14(17–18):876–84. Strauss DG, Gintant G, Li Z, Wu W, Blinova K, Vicente J, et al. Ther Innov Regul Sci. 2018;53(4):519–25. Neurotoxicology. 2010 Aug;31(4):331–50.

Drugs 111

Drugs FDA Disease Animal Testing 111

Agency IQ

NOVEMBER 27, 2023

Key Documents and Dates Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner Comments on Proposed Rule (Docket No: FDA-2009-N-0582)

FDA 40

FDA Science Drugs Regulations 40

The Pharma Data

AUGUST 1, 2021

The option for Medarex to co-promote the product expired on its acquisition by Bristol-Myers Squibb (BMS) in 2009. The Company’s early respiratory research is focused on emerging science involving immune mechanisms, lung damage and abnormal cell-repair processes in disease and neuronal dysfunction.

Trials 52

Trials Therapies Disease Treatment 52

Drug Target Review

APRIL 8, 2024

In 2009, he became the Joseph R. He was awarded the 2013 Distinguished Alumnus of the Year by the School of Physical Sciences at the University of California, Irvine, was elected to the Association of American Physicians in 2010 and is a member of Phi Beta Kappa and the Alpha Omega Alpha Medical Honor Societies. Coulter Jr.

Hospitals 52

Hospitals Therapies Clinical Trials Molecular Biology 52

The Pharma Data

APRIL 28, 2022

These proposed product standards are based on clear science and evidence establishing the addictiveness and harm of these products and build on the Family Smoking Prevention and Tobacco Control Act, which prohibited all characterizing flavors (other than tobacco and menthol) in cigarettes in 2009.

FDA 52

FDA Disease Production Regulations 52

LifeSciVC

DECEMBER 13, 2022

We wouldn’t be here today if it weren’t for our exceptional science-driven organization and culture at Nimbus. During the spring of 2009, when the markets hit bottom, Schrödinger’s Ramy Farid and I co-founded the company, then called Project Troubled Water, and we incubated it in the Atlas offices.

Clinical Trials 40

Clinical Trials Trials Engineering Disease 40

PLOS: DNA Science

MARCH 30, 2023

Tracking the New Pathogen The initial clinical identification of Candida auris was in Japan in 2009, but stored cultures reveal that it goes back to at least 1996, in South Korea. The post The New Fungus Among Us, Candida auris appeared first on DNA Science. It’s an old technique. Imagine if we could have done that with COVID!

DNA 52

DNA Hospitals Laboratories Virus 52

Codon

APRIL 9, 2023

“Computer science is to biology what calculus is to physics.” Read Basic Science *mRNA decoding in human is kinetically and structurally distinct from bacteria. Science Translational Medicine. Science Translational Medicine. Science Advances. My goal is to reach 100 supporters! Thank you for being here.

Therapies 52

Therapies RNA Engineering Vaccine 52

PLOS: DNA Science

OCTOBER 17, 2024

The new drug is taken with miglustat , which FDA approved for use in NPD3 in 2009. The post New Drug Miplyffa Approved for Rare Niemann-Pick Disease Type 3 appeared first on DNA Science. The original approved was in 2003 to treat a type of Gaucher disease. Center for Translational Research at Rush University Medical Center.

Disease 52

Disease FDA Approval Drugs Treatment 52

The Pharma Data

DECEMBER 20, 2020

a pioneer in the development of trans-catheter aortic valve implantation, which was supported early on by leading European life sciences venture capital firm Sofinnova Partners until the sale to Medtronic in 2009 for more than $700 million.

Licensing 40

Licensing Licensing Production Treatment 40